- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06637358
A Text-based Reduction Intervention for Smokeless Tobacco Cessation- Pilot Study
December 12, 2025 updated by: Duke University
All participants will receive the EnufSnuff.TXT scheduled gradual reduction (SGR) intervention for 6 weeks and, for those who do not reach the point of quit, includes getting randomized (like the flip of a coin) into either an additional 8-10 weeks of the EnufSnuff.TXT intervention or into receiving an additional 8-10 weeks of the EnufSnuff.TXT intervention along with a dedicated text quit coach to send and receive live support.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
All participants will receive the EnufSnuff.TXT intervention (a text-based personalized reduction plan and daily text-based cessation support messages) for 6 weeks and, for those who report that they have not achieved complete cessation, includes getting randomized into either an additional 8-10 weeks of the EnufSnuff.TXT intervention or into receiving an additional 8-10 weeks of the EnufSnuff.TXT intervention along with a dedicated quit coach to send and receive live text support.
The investigators will conduct phone-based or smart phone-based assessments with participants at baseline, end of program, and 7-month follow-up after intervention completion.
The investigators will also conduct a brief midpoint check (after the first 6 weeks of intervention) with participants to ask if they have quit using smokeless tobacco.
Research staff will email participants redcap surveys at baseline, end of program, and 7-months.
Participants will be able to opt for a recorded telephone interview at the 7-month check-in.
Each opted-in participant will be interviewed only once.
Study Type
Interventional
Enrollment (Actual)
69
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
North Carolina
-
Durham, North Carolina, United States, 27708
- Duke University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- 18 years of age and older
- Have used smokeless tobacco for the last year, currently dip 3 or more times a day
- Have an address in a rural census tract defined by a RUCC code of 4-10 and/or an IMU of 62 or lower
- Interested in participating in a cessation program; and
- Have access to a cell phone with unlimited texting ability.
Exclusion Criteria:
- Non-English speaking;
- Have smoked cigarettes or used any other tobacco product in the past 30 days (i.e., dual user) and are not willing to abstain during the intervention period
- Currently participating in a smokeless tobacco cessation study.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Extended Scheduled Gradual Reduction (SGR)
Extended scheduled gradual reduction.
Participants are asked to gradually reduce smokeless tobacco usage.
|
The extended SGR program will allow participants additional time to reduce smokeless tobacco use until they reach zero.
The intent of this program is to reduce the number of times participants use smokeless tobacco down to zero.
Participants will also receive text-based support messages.
|
|
Experimental: Quit Coach and Extended Scheduled Gradual Reduction (SGR)
Extended scheduled gradual reduction given with the extra support of a live text-based coach.
Participants are asked to gradually reduce smokeless tobacco usage and engage in weekly check-ins with their assigned quit coach.
|
The extended SGR program will allow participants additional time to reduce smokeless tobacco use until they reach zero.
The intent of this program is to reduce the number of times participants use smokeless tobacco down to zero.
Participants will also receive text-based support messages.
Weekly check-ins and support will be given to this group via the quit coach interactions.
The intent of this program is to reduce the number of times participants use smokeless tobacco down to zero.
Participants will also receive text-based support messages.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Feasibility as measured by the number of recruited individuals who enrolled
Time Frame: Baseline
|
Baseline
|
|
|
Feasibility as measured by the number of participants who left the study (attrition)
Time Frame: Up to 6 months
|
Up to 6 months
|
|
|
Acceptability as measured by the number of participants who found the intervention useful
Time Frame: Up to 6 months
|
As measured via telephone interview.
|
Up to 6 months
|
|
Acceptability as measured by the number of participants who reported that the intervention received changed their smokeless tobacco use
Time Frame: Up to 6 months
|
As measured via telephone interview.
|
Up to 6 months
|
|
Acceptability as measured by the number of participants who reported that the intervention made them think about quitting
Time Frame: Up to 6 months
|
As measured via telephone interview.
|
Up to 6 months
|
|
Acceptability as measured by the number of participants who reported that they would recommend the program to a friend
Time Frame: Up to 6 months
|
As measured via telephone interview.
|
Up to 6 months
|
|
Preliminary efficacy as measured by the number of participants who quit smokeless tobacco by the end of treatment
Time Frame: Up to approximately 16 weeks
|
Up to approximately 16 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Devon Noonan, PhD, Duke University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
November 5, 2024
Primary Completion (Actual)
November 4, 2025
Study Completion (Actual)
November 4, 2025
Study Registration Dates
First Submitted
October 9, 2024
First Submitted That Met QC Criteria
October 9, 2024
First Posted (Actual)
October 15, 2024
Study Record Updates
Last Update Posted (Actual)
December 16, 2025
Last Update Submitted That Met QC Criteria
December 12, 2025
Last Verified
December 1, 2025
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Pro00103410 _1
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Smokeless Tobacco Cessation
-
Duke UniversityNational Cancer Institute (NCI)Completed
-
Oregon Research InstituteNational Cancer Institute (NCI); Mayo ClinicCompletedSmokeless Tobacco CessationUnited States
-
Duke UniversityCompletedSmokeless Tobacco CessationUnited States
-
Duke UniversityNational Cancer Institute (NCI)CompletedSmokeless Tobacco CessationUnited States
-
HealthPartners InstituteMinnesota Partnership for Action Against TobaccoCompleted
-
Lehigh UniversityAmerican Cancer Society, Inc.RecruitingSmokeless Tobacco CessationUnited States
-
Roswell Park Cancer InstituteCompletedTobacco Use | Tobacco Smoking | Cigarette Smoking | Smokeless Tobacco CessationUnited States
-
Contract Research Organization el ABSwedish Match ABCompletedSmoking Cessation | Harm Reduction | Smokeless TobaccoSweden
-
Contract Research Organization el ABSwedish Match ABCompletedSmoking Cessation | Harm Reduction | Smokeless TobaccoSweden
-
Aga Khan UniversityDow University of Health SciencesCompletedSmokeless Tobacco CessationPakistan
Clinical Trials on Extended Scheduled Gradual Reduction (SGR)
-
Duke UniversityNational Cancer Institute (NCI)CompletedSmokeless Tobacco CessationUnited States
-
Duke UniversityNational Cancer Institute (NCI)CompletedSmoking | PregnancyUnited States
-
Icahn School of Medicine at Mount SinaiNational Institute on Drug Abuse (NIDA)TerminatedNicotine AddictionUnited States
-
University of California, San FranciscoQuitbit, Inc.Completed
-
Mount Sinai Hospital, CanadaHeart and Stroke Foundation of CanadaRecruitingAppetite Regulation | Weight Change | Obesity (Disorder) | Blood Pressure MonitoringCanada
-
VA Office of Research and DevelopmentCompletedInsomniaUnited States
-
Wake Forest University Health SciencesNational Institute on Drug Abuse (NIDA)CompletedTobacco Smoking | Nicotine DependenceUnited States
-
UCB PharmaCompletedAttention Deficit Hyperactivity Disorder
-
UMC UtrechtNational University Hospital, Singapore; Berry Consultants; University of Pittsburgh... and other collaboratorsRecruitingCommunity-acquired Pneumonia, Influenza, COVID-19United Kingdom, United States, Canada, Australia, Netherlands, Spain, Croatia, Belgium, New Zealand, Ireland, France, Italy, Japan, Slovenia, Colombia, India, Nepal, Pakistan, Portugal, Saudi Arabia, Germany, Israel, Czechia, Estonia, F... and more